Cargando…
Targeting of CCN2 suppresses tumor progression and improves chemo-sensitivity in urothelial bladder cancer
Urothelial bladder cancer (UBC) is the most common urinary neoplasm in China. CCN family protein 2 (CCN2), a cysteine-rich matricellular protein, is abnormally expressed in several cancer types and involved in tumor progression or chemo-resistance. However, detailed expression patterns and effects o...
Autores principales: | Wang, Xiaojing, Xu, Tianyuan, Gao, Fengbin, He, Hongchao, Zhu, Yu, Shen, Zhoujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630414/ https://www.ncbi.nlm.nih.gov/pubmed/29029514 http://dx.doi.org/10.18632/oncotarget.19987 |
Ejemplares similares
-
MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5
por: Xu, Tianyuan, et al.
Publicado: (2016) -
CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells
por: Gao, Fengbin, et al.
Publicado: (2018) -
CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing β-catenin
por: Gao, Fengbin, et al.
Publicado: (2017) -
Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis
por: Dong, Fan, et al.
Publicado: (2018) -
Nomograms to Predict Individual Prognosis of Patients with Primary Small Cell Carcinoma of the Bladder
por: Dong, Fan, et al.
Publicado: (2018)